Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis

The clinical therapeutics of cervical cancer is limited due to the drug resistance and metastasis of tumor. As a novel target for antitumor therapy, ferroptosis is deemed to be more susceptible for those cancer cells with resistance to apoptosis and chemotherapy. Dihydroartemisinin (DHA), the primar...

Full description

Bibliographic Details

Published in:	Frontiers in Molecular Biosciences
Main Authors:	Hanqiang Shi, Lie Xiong, Guang Yan, Shuqin Du, Jie Liu, Yanbo Shi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Subjects:	cervical cancer dihydroartemisinin ferroptosis ferritinophagy heme oxygenase-1 doxorubicin
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2023.1156062/full